JABET Explore more articles

Table 2. Antibiotic susceptibility pattern of E. coli in male and female patients.  

 

Antibiotic

Pattern

Gender

Total

P

Value

Male

% (n)

Female

%(n)

Amoxycillin

(20 μg)

S

13.7 (21)

9.0 (27)

10.6 (48)

0.085

R

86.3(132)

91.0 (273)

89.4 (405)

Cephradine

(30 μg)

S

35.3(54)

24.0 (72)

27.8 (126)

0.014*

 

 I

3.9(6)

2.0 (6)

2.6 (12)

R

60.8 (93)

74.0 (222)

69.5 (315)

Ceftriaxone

(30 μg)

S

43.1 (66)

108(36.0)

38.4 (174)

0.186

 

 I

0.0(0)

1.0 (3)

.7 (3)

R

56.9 (87)

63.0 (189)

60.9 (276)

Ceftazidime

(30 μg)

 

S

52.9 (81)

44.0 (132)

47.0 (213)

0.093

 I

7.8 (12)

6.0 (18)

6.6 (30)

R

39.2 (60)

50.0 (150)

46.4 (210)

Imipenem

(10 μg)

S

90.2 (138)

92.0 (276)

91.4 (414 ()

0.002*

 

 I

3.9 (6)

0.0(0)

1.3 (6)

R

5.9 (9)

8.0 (24)

7.3 (33)

Erythromycin

(15 μg)

S

3.9 (6)

1.0 (3)

2.0 (9)

0.04*

 

R

96.1 (147)

99.0 (297)

98.0 (444)

Co_trimoxazole

(25μg)

S

19.6 (30)

22.0 (66)

21.2 (96)

0.546

 

 I

0.0(0)

1.0 (3)

.7 (3)

R

80.4 (123)

77.0 (231)

78.1 (354)

Moxifloxacin

(5 μg)

S

37.3 (57)

32.0 (96)

33.8 (153)

0.361

 I

11.8 (18)

10.0 (30)

10.6 (48)

R

51.0 (78)

58.0 (174)

55.6 (252)

Gentamicin

(10 μg)

S

68.6 (105)

55.0 (165)

59.6 (270)

0.004*

 I

5.9 (9)

15.0 (45)

11.9 (54)

R

25.5 (39)

30.0 (90)

28.5 (129)

Netilmycin

(30 μg)

S

72.5 (111)

70.0 (210)

321(70.9)

0.328

 I

5.9 (9)

10.0 (30)

8.6 (3939)

R

21.6 (33)

20.0 (60)

20.5 (93)

Nalidixic_Acid

(30 μg)

S

29.4 (45)

15.0 (45)

19.9 (90)

0.001*

 

 I

0.0(0)

1.0 (3)

0.7 (3)

R

70.6 (108)

84.0 (252)

79.5 (360)

Ciprofloxacin

(5 μg)

S

39.2 (60)

34.0 (102)

35.8 (162)

0.022*

 I

7.8 (12)

3.0 (9)

4.6 (21)

R

52.9 (81)

63.0 (189)

59.6 (270)

Levofloxacin

(5 μg)

S

43.1 (66)

36.0 (108)

38.4 (174)

0.004*

 I

11.8 (18)

5.0 (15)

7.3 (33)

R

45.1 (69)

59.0 (177)

54.3 (246)

Nitrofurantoin

(300 μg)

S

78.4 (120)

85.0 (255)

82.8 (375)

0.013*

 

 I

0.0(0)

2.0 (6)

1.3 (6)

R

21.6 (33)

13.0 (39)

15.9 (72)

Amikacin

(30 μg)

S

76.5 (117)

72.0 (216)

73.5 (333)

0.432

 I

5.9(9)

9.0 (27)

7.9 (36)

R

17.6 (27)

19.0 (57)

18.5 (84)

Aztreonam

(30 μg)

S

31.4 (48)

32.0 (96)

31.8 (144)

0.012*

 I

15.7 (24)

7.0 (21)

9.9 (45)

R

52.9 (81)

61.0 (183)

58.3 (264)

(n)- indicates the number of patients, *Using Fisher Exact test because expected frequency < 0.05. S=Sensitive, I=Intermediate, R=Resistant